Theratechnologies Inc T.TH

They act like big pharma. That's a problem

[Joemare]

This tiny biotech, few employees in the US and Canada, mostly head-office or work-at-home, acts like a major pharma company.  They cannot turn on a dime. Everything takes so much time. Why? They act as a big pharma - consultants on marketing, consultants on strategy, consultants on financing, consultants on a reorg.,  consultants, consultants, consultants....painfult way of conducting business when you think you are big but actually a very very small fish.

That's a major problem. They need to behavre like entrepreneurs. And if they don't have that skill set, fire them!  THey think they have such a big ship to steer. That vision has to quickly change and evolve.

From my experience and turn of events, it's at least 10 weeks they know they 'failed' their phase I.  It's at least 6 months they have had issue with patient accrual.  And here we are, still waiting for the ship to be steered on a clearer path.  That has to change.  It's unacceptable.

[Trogarzon]

Totally agree.  But firing them can't happen before votin time in may and without big shareholders support.  In the mean time, if they are scared of being fired maybe they throw us under the bus with another OO and dilute us into oblivion.  Also, once they're gone what do you do, you can't replace everyone overthere, it's too late for that now.  So you call

[Wino115]

As they have stated in the new Presentation, there is both a financial plan and a plan around answering whatever questions they can from the trial data. The financial plan will have to be elaborated on in the next quarterly call in Feb and given how analysts have always focused on those numbers to begin with, for once all their questions will actually be some of the most important. So we will find

[scarlet1967]

In my opinion lack of transparent factual and frequent updates to broader market has caused skepticism which was holding back the valuation in the past and if not addressed will be an issue going forward. Starting with commercial drugs the company overestimated the markets by miles didn't correct it when the sales kept disappointing based on the inflated expectations and they waited for too

[houbahop]

Bravo! Finally acknowledging the resulting behaviour (towards shareholders) of a flawed business culture running inside the walls of this company. Don't blame the various individuals holding the Investors Relations seat in the past. They probably have left because of the sloppy communication job they were required to do. The problem is up there, somewhere. The only way to stop this is to

[Joemare]

Well said. We don't even work for the company and we can clearly paint a clear picture of what's going on in there for the past three-four years. It's quite an accomplishment for this board. Our gift to them - they can skip paying another consultant doing a deep-dive in their business.